Keyphrases
Endometrial Cancer
100%
Minimally Invasive Surgery
100%
Lower Uterine Segment
100%
Minimally Invasive Approach
100%
Laparotomy
71%
Recurrence Rate
28%
Locoregional Recurrence
28%
Non-associated
14%
Odds Ratio
14%
Between-group
14%
Confidence Interval
14%
Comorbidity
14%
Progression-free Survival
14%
Overall Survival
14%
Surgery Groups
14%
Tumor Grade
14%
Disease Stage
14%
Adjuvant Chemotherapy
14%
Cox Regression Model
14%
Multicenter Cohort Study
14%
Log-rank Test
14%
Adjuvant Therapy
14%
Univariate Analysis
14%
Endometrial Carcinoma
14%
Stage II-III
14%
Adjuvant Radiation
14%
Kaplan-Meier Survival
14%
Advanced Endometrial Carcinoma
14%
Cox Proportional Hazard Analysis
14%
Oncological Outcomes
14%
Pharmacology, Toxicology and Pharmaceutical Science
Retrospective Study
100%
Recurrence Risk
100%
Endometrium Cancer
100%
Endometrium Carcinoma
100%
Cohort Study
50%
Chemotherapy
50%
Recurrent Disease
50%
Comorbidity
50%
Overall Survival
50%
Progression Free Survival
50%
Disease
50%
Neoplasm
50%
Medicine and Dentistry
Endometrial Cancer
100%
Retrospective Study
100%
Minimally Invasive Surgery
100%
Laparotomy
71%
Recurrence Risk
28%
Proportional Hazards Model
28%
Endometrium Carcinoma
28%
Neoplasm
14%
Disease
14%
Recurrent Disease
14%
Overall Survival
14%
Progression Free Survival
14%
Odds Ratio
14%
Cohort Analysis
14%
Log Rank Test
14%
Univariate Analysis
14%
Adjuvant Therapy
14%